FDA Nominee Addresses Vaccine Safety During Senate Hearing

Why it matters locally: The Food and Drug Administration's decisions on vaccine safety and childhood immunization initiatives directly affect public health guidelines and practices within New Jersey, influencing local healthcare providers and residents. Any changes in FDA leadership or policy could impact the availability and public trust in vaccines across the state.

---

WASHINGTON – Heidi Overton, President Donald Trump's nominee to lead the Food and Drug Administration (FDA), spoke to senators Thursday during her confirmation hearing. Overton addressed the safety of long-established vaccines. Senators questioned Overton on the White House's initiatives regarding childhood immunizations. Her testimony followed President Trump's nomination for the FDA's top role.